Tumor reduction formulations and methods of use thereof
AssigneeTyme, Inc.
InventorsSteven Hoffman, John Rothman
Life of this patent
Estimating the term…
Abstract
The invention relates to tumor reducing compositions and methods thereof. Specifically, the invention relates to compositions comprising a combination of a sclerosing agent and a penetrating agent.
Claims35
A pharmaceutical composition comprising a combination of a sclerosing agent and a penetrating agent.
A pharmaceutical composition comprising a bile acid, nonaethylene glycol monododecyl ether, and anhydrous 1-methyl-2-pyrrolidinone.
A method of reducing a size of a tumor in a subject, comprising contacting a tumor with a composition comprising a therapeutically effective amount of a combination of a sclerosing agent and a penetrating agent.
A method of reducing a size of a tumor in a subject, comprising contacting a tumor with a composition comprising a therapeutically effective amount of a combination of a sclerosing agent and a penetrating agent, and a bile acid.
Dependencies are inferred from the claim text.